Ownership

13F as of Q2 2026 · 2.6M shares outstanding

Who owns CANF?

By type of holder

Institutions 0.0% Insiders 0.0% Everyone else 100.0%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Can Fite Biopharma Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+161.6%

+21.20% a year

Each share's claim on the business

−61.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $2.05M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding CANF.

Super Investors

Investment managers reporting CANF on Form 13F

No 13F manager reports holding CANF yet.

Institutional Funds

Mutual funds and ETFs reporting CANF on Form N-PORT; together they hold 0.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
BA Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	$-160	—	-0.03%	0.00%	December 31, 2025

Blackstone Alternative Multi-Strategy Fund

Blackstone Alternative Investment Funds

Position value

$-160

% of company

-0.03%

% of the fund

0.00%

As of

December 31, 2025

Comments